Triple-Negative Breast Cancer, Stem Cells, and African Ancestry
- PMID: 29137951
- DOI: 10.1016/j.ajpath.2017.06.020
Triple-Negative Breast Cancer, Stem Cells, and African Ancestry
Abstract
Triple-negative breast cancers (TNBCs) are more common among African-ancestry populations, such as African Americans and western, sub-Saharan Africans, compared with European-ancestry populations. This phenotype prevalence contributes to disparities in breast cancer outcomes between African Americans and White Americans. Breast cancer stem cells represent the tumor subpopulation involved in metastatic virulence, and ongoing research seeks to characterize the extent to which TNBC versus non-TNBC stem cells may differ. This review summarizes the existing literature regarding TNBCs and stem cells as they pertain to the burden of breast cancer among African-ancestry populations. Additional research related to variations in somatic tumor genomics between the African-American and White-American populations is also summarized. This review furthermore explores the history of insights regarding breast cancer disparities related to racial/ethnic identity, socioeconomic status, and tumor biology.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.JAMA Surg. 2017 May 1;152(5):485-493. doi: 10.1001/jamasurg.2017.0005. JAMA Surg. 2017. PMID: 28355428 Review.
-
Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.Ann Surg Oncol. 2016 Nov;23(12):3843-3849. doi: 10.1245/s10434-016-5420-z. Epub 2016 Jul 28. Ann Surg Oncol. 2016. PMID: 27469125
-
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.Breast Cancer Res Treat. 2021 Apr;186(2):391-401. doi: 10.1007/s10549-021-06097-8. Epub 2021 Feb 12. Breast Cancer Res Treat. 2021. PMID: 33576900
-
Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.Breast Cancer Res Treat. 2020 Jul;182(2):503-509. doi: 10.1007/s10549-020-05693-4. Epub 2020 May 21. Breast Cancer Res Treat. 2020. PMID: 32441016 Free PMC article.
-
Disparities in breast cancer and african ancestry: a global perspective.Breast J. 2015 Mar-Apr;21(2):133-9. doi: 10.1111/tbj.12369. Epub 2015 Jan 9. Breast J. 2015. PMID: 25639288 Review.
Cited by
-
A pH-triggered N-oxide polyzwitterionic nano-drug loaded system for the anti-tumor immunity activation research.J Nanobiotechnology. 2024 Jul 16;22(1):420. doi: 10.1186/s12951-024-02677-0. J Nanobiotechnology. 2024. PMID: 39014462 Free PMC article.
-
HSD17B7 gene in self-renewal and oncogenicity of keratinocytes from Black versus White populations.EMBO Mol Med. 2021 Jul 7;13(7):e14133. doi: 10.15252/emmm.202114133. Epub 2021 Jun 29. EMBO Mol Med. 2021. PMID: 34185380 Free PMC article.
-
Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.Curr Breast Cancer Rep. 2020 Sep;12(3):125-131. doi: 10.1007/s12609-020-00364-1. Epub 2020 May 19. Curr Breast Cancer Rep. 2020. PMID: 33603954 Free PMC article.
-
A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer.iScience. 2021 Apr 19;24(5):102451. doi: 10.1016/j.isci.2021.102451. eCollection 2021 May 21. iScience. 2021. PMID: 34007962 Free PMC article.
-
Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia.Front Endocrinol (Lausanne). 2023 Nov 9;14:1250189. doi: 10.3389/fendo.2023.1250189. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027092 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources